Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Angioplasty and adeno-tonsillectomy in latest NHS HTA reports

This article was originally published in Clinica

Executive Summary

Infra-inguinal percutaneous transluminal angioplasty (PTA) and adeno-tonsillectomy are among the themes of the latest reports of the UK NHS's health technology assessment (HTA) programme. The former is a report on the results of a multi-centre randomised controlled trial of the cost-effectiveness of infra-inguinal PTA versus reconstructive surgery for severe limb ischaemia (BASIL); the latter is on the results of the North of England study of tonsillectomy and adeno-tonsillectomy in children (NESSTAC). The NHS HTA programme is funded by the National Institute for Health Research (NIHR), with contributions from its Scottish (CSO) and Welsh (WORD) counterparts.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT081898

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel